Needham analyst David Saxon reiterated a Buy rating on Alphatec Holdings today and set a price target of $22.00.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
David Saxon has given his Buy rating due to a combination of factors including Alphatec Holdings’ impressive financial performance in the third quarter of 2025. The company’s revenue exceeded market expectations by approximately 8%, which was a positive surprise for investors. Additionally, the growth in the active surgeon base by 26% serves as a strong indicator of future demand and business expansion.
Moreover, the EOS segment also experienced significant growth, contributing positively to the overall financial results. Alphatec Holdings achieved $5 million in free cash flow, marking a shift to positive free cash flow on a trailing twelve-month basis. This financial momentum suggests potential for upward revisions in future estimates, prompting the reaffirmation of the Buy rating and an increase in the price target to $22.
Saxon covers the Healthcare sector, focusing on stocks such as DENTSPLY SIRONA, Irhythm Technologies, and Alcon. According to TipRanks, Saxon has an average return of -0.1% and a 36.72% success rate on recommended stocks.
In another report released today, H.C. Wainwright also maintained a Buy rating on the stock with a $24.00 price target.